Trial Profile
A Study to Evaluate the Pharmacokinetic Interaction between Ertugliflozin and Glimepiride in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Ertugliflozin (Primary) ; Glimepiride (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 22 Apr 2016 New trial record
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics